PANC OTC
Panacos Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -90.0%
5Y: -82.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$31M
-4.7% ▼
Capital Expenditures
$48K
+90.8% ▲
5Y CAGR: -49.6%
Free Cash Flow
-$31M
-3.1% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$5M
+108.8% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2003 | FY2004 | FY2005 | FY2006 | FY2007 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$5M | -$12M | -$59M | -$38M | -$37M |
| Depreciation & Amort. | $138K | $227K | $629K | $751K | $794K |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $419K | $1M | -$348K | -$44K | $868K |
| Other Non-Cash Items | $0 | $604K | $37M | $8M | $5M |
| Operating Cash Flow | -$4M | -$10M | -$22M | -$30M | -$31M |
| — Investing Activities — | |||||
| Capital Expenditures | -$8K | -$76K | -$150K | -$519K | -$48K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | -$270M | -$235M |
| Investment Sales | $0 | $0 | $0 | $244M | $251M |
| Other Investing | $0 | -$451K | $556K | $51K | $0 |
| Investing Cash Flow | -$8K | -$527K | $406K | -$26M | $15M |
| — Financing Activities — | |||||
| Net Debt Issuance | $3M | -$185K | -$1M | $148K | $20M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 | -$31K | -$332K |
| Financing Cash Flow | $3M | $15M | $103M | $2M | $21M |
| Net Change in Cash | -$1M | $4M | $82M | -$54M | $5M |
| Cash End of Period | $477K | $5M | $87M | $33M | $38M |
| Free Cash Flow | -$4M | -$10M | -$22M | -$30M | -$31M |